[go: up one dir, main page]

GB0722015D0 - Transdermal therapy - Google Patents

Transdermal therapy

Info

Publication number
GB0722015D0
GB0722015D0 GBGB0722015.5A GB0722015A GB0722015D0 GB 0722015 D0 GB0722015 D0 GB 0722015D0 GB 0722015 A GB0722015 A GB 0722015A GB 0722015 D0 GB0722015 D0 GB 0722015D0
Authority
GB
United Kingdom
Prior art keywords
transdermal therapy
transdermal
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB0722015.5A
Other versions
GB2443928A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tiziana Life Sciences Ltd
Original Assignee
Regen Therapeutics PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0622285A external-priority patent/GB0622285D0/en
Priority claimed from GB0705689A external-priority patent/GB0705689D0/en
Application filed by Regen Therapeutics PLC filed Critical Regen Therapeutics PLC
Publication of GB0722015D0 publication Critical patent/GB0722015D0/en
Publication of GB2443928A publication Critical patent/GB2443928A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
GB0722015A 2006-11-08 2007-11-08 Transdermal pharmaceutical composition comprising Zolpidem Withdrawn GB2443928A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0622285A GB0622285D0 (en) 2006-11-08 2006-11-08 Transdermal therapy
GB0705689A GB0705689D0 (en) 2007-03-21 2007-03-21 Therapeutic applications of Zolpidem

Publications (2)

Publication Number Publication Date
GB0722015D0 true GB0722015D0 (en) 2007-12-19
GB2443928A GB2443928A (en) 2008-05-21

Family

ID=38858432

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0722015A Withdrawn GB2443928A (en) 2006-11-08 2007-11-08 Transdermal pharmaceutical composition comprising Zolpidem

Country Status (2)

Country Link
GB (1) GB2443928A (en)
WO (1) WO2008056139A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0809936D0 (en) * 2008-05-30 2008-07-09 Regen Therapeutics Plc Therapeutic use of zolpidem

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI921121A0 (en) * 1989-09-14 1992-03-16 Cygnus Research Corp TRANSDERMAL DOSERINGSANORDNING MED FOERDROEJD START.
IT1276522B1 (en) * 1995-04-07 1997-10-31 Elena Benincasa USE OF ZOLPIDEM FOR THE THERAPEUDIC TREATMENT OF NEUROPSYCHIATRIC SYNDROMES ASSOCIATED WITH DYSFUNSION AND NEURAL CIRCUITS OF
US7632517B2 (en) * 1997-10-01 2009-12-15 Novadel Pharma Inc. Buccal, polar and non-polar spray containing zolpidem
EP1005863A1 (en) * 1998-12-04 2000-06-07 Synthelabo Controlled-release dosage forms comprising a short acting hypnotic or a salt thereof
US20030104041A1 (en) * 1999-12-16 2003-06-05 Tsung-Min Hsu Transdermal and topical administration of drugs using basic permeation enhancers
WO2001052823A2 (en) * 2000-01-20 2001-07-26 Noven Pharmaceuticals, Inc. Compositions to effect the release profile in the transdermal administration of drugs
US20040139705A1 (en) * 2000-03-14 2004-07-22 Noven Pharmaceuticals, Inc. Packaging materials for transdermal drug delivery systems
US6635274B1 (en) * 2000-10-27 2003-10-21 Biochemics, Inc. Solution-based transdermal drug delivery system
WO2004066930A2 (en) * 2003-01-27 2004-08-12 Arthur Zaks Method for inducing pain relief using imidazo[1,2-a]pyridine derivatives
JP2008506630A (en) * 2003-05-19 2008-03-06 サイエンコム・リミテッド Further therapeutic use of zolpidem
GB0329918D0 (en) * 2003-12-24 2004-01-28 West Pharm Serv Drug Res Ltd Intranasal compositions
US8246976B2 (en) * 2004-10-08 2012-08-21 Noven Pharmaceuticals, Inc. Transdermal delivery of drugs based on crystal size
MX2007004315A (en) * 2004-10-08 2008-03-11 Noven Pharma Transdermal drug delivery device including an occlusive backing.

Also Published As

Publication number Publication date
GB2443928A (en) 2008-05-21
WO2008056139A3 (en) 2008-10-02
WO2008056139A2 (en) 2008-05-15

Similar Documents

Publication Publication Date Title
IL196559A0 (en) Combination therapy
GB2436010B (en) Therapy device
ZA200803882B (en) Transdermal Therapeutic System
GB0602178D0 (en) Therapeutic treatment
GB0712494D0 (en) Substrate reduction therapy
IL196556A0 (en) Combination therapy
IL199992A0 (en) Combination therapy
HRP20130041T8 (en) Therapeutic agents
EP2054061A4 (en) Combination therapy
EP2247319A4 (en) Therapy device
GB0723747D0 (en) Therapeutic agents
GB0719518D0 (en) Therapy
ZA200902203B (en) Combination therapy
ZA200809004B (en) Autodestructive transdermal therapeutic system
IL198026A0 (en) Sequential combination therapy
GB0608655D0 (en) Therapeutic Treatment
EP2211863A4 (en) Combination therapy
GB0610909D0 (en) Therapeutic treatment
GB0700284D0 (en) Combination therapy
GB0723748D0 (en) Therapeutic agents
GB0722015D0 (en) Transdermal therapy
GB0606660D0 (en) Targeted Therapy
GB0716072D0 (en) Therapy
GB0700635D0 (en) Therapy
GB0622285D0 (en) Transdermal therapy

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)